160 related articles for article (PubMed ID: 22918253)
1. Oncogenic transcription factors as master regulators of chromatin topology: a new role for ERG in prostate cancer.
Elemento O; Rubin MA; Rickman DS
Cell Cycle; 2012 Sep; 11(18):3380-3. PubMed ID: 22918253
[TBL] [Abstract][Full Text] [Related]
2. Oncogene-mediated alterations in chromatin conformation.
Rickman DS; Soong TD; Moss B; Mosquera JM; Dlabal J; Terry S; MacDonald TY; Tripodi J; Bunting K; Najfeld V; Demichelis F; Melnick AM; Elemento O; Rubin MA
Proc Natl Acad Sci U S A; 2012 Jun; 109(23):9083-8. PubMed ID: 22615383
[TBL] [Abstract][Full Text] [Related]
3. Chromosome compartmentalization alterations in prostate cancer cell lines model disease progression.
San Martin R; Das P; Dos Reis Marques R; Xu Y; Roberts JM; Sanders JT; Golloshi R; McCord RP
J Cell Biol; 2022 Feb; 221(2):. PubMed ID: 34889941
[TBL] [Abstract][Full Text] [Related]
4. Capturing Chromosome Conformation.
Pucéat M
Methods Mol Biol; 2021; 2157():1-7. PubMed ID: 32820395
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of Interplay between Transcription Factors and the 3D Genome.
Kim S; Shendure J
Mol Cell; 2019 Oct; 76(2):306-319. PubMed ID: 31521504
[TBL] [Abstract][Full Text] [Related]
6. Expanding the effects of ERG on chromatin landscapes and dysregulated transcription in prostate cancer.
Babu D; Fullwood MJ
Nat Genet; 2017 Aug; 49(9):1294-1295. PubMed ID: 28854182
[TBL] [Abstract][Full Text] [Related]
7. TMPRSS2-ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer.
Kron KJ; Murison A; Zhou S; Huang V; Yamaguchi TN; Shiah YJ; Fraser M; van der Kwast T; Boutros PC; Bristow RG; Lupien M
Nat Genet; 2017 Sep; 49(9):1336-1345. PubMed ID: 28783165
[TBL] [Abstract][Full Text] [Related]
8. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer.
Tomlins SA; Laxman B; Dhanasekaran SM; Helgeson BE; Cao X; Morris DS; Menon A; Jing X; Cao Q; Han B; Yu J; Wang L; Montie JE; Rubin MA; Pienta KJ; Roulston D; Shah RB; Varambally S; Mehra R; Chinnaiyan AM
Nature; 2007 Aug; 448(7153):595-9. PubMed ID: 17671502
[TBL] [Abstract][Full Text] [Related]
9. Human transcriptional interactome of chromatin contribute to gene co-expression.
Dong X; Li C; Chen Y; Ding G; Li Y
BMC Genomics; 2010 Dec; 11():704. PubMed ID: 21156067
[TBL] [Abstract][Full Text] [Related]
10. Cysteine-rich secretory protein-3 (CRISP3) is strongly up-regulated in prostate carcinomas with the TMPRSS2-ERG fusion gene.
Ribeiro FR; Paulo P; Costa VL; Barros-Silva JD; Ramalho-Carvalho J; Jerónimo C; Henrique R; Lind GE; Skotheim RI; Lothe RA; Teixeira MR
PLoS One; 2011; 6(7):e22317. PubMed ID: 21814574
[TBL] [Abstract][Full Text] [Related]
11. ERF mutations reveal a balance of ETS factors controlling prostate oncogenesis.
Bose R; Karthaus WR; Armenia J; Abida W; Iaquinta PJ; Zhang Z; Wongvipat J; Wasmuth EV; Shah N; Sullivan PS; Doran MG; Wang P; Patruno A; Zhao Y; ; Zheng D; Schultz N; Sawyers CL
Nature; 2017 Jun; 546(7660):671-675. PubMed ID: 28614298
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.
Simmonds P; Loomis E; Curry E
Genome Med; 2017 Jun; 9(1):54. PubMed ID: 28592290
[TBL] [Abstract][Full Text] [Related]
13. Novel insights into chromosomal conformations in cancer.
Jia R; Chai P; Zhang H; Fan X
Mol Cancer; 2017 Nov; 16(1):173. PubMed ID: 29149895
[TBL] [Abstract][Full Text] [Related]
14. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM
PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932
[TBL] [Abstract][Full Text] [Related]
15. The genomic complexity of primary human prostate cancer.
Berger MF; Lawrence MS; Demichelis F; Drier Y; Cibulskis K; Sivachenko AY; Sboner A; Esgueva R; Pflueger D; Sougnez C; Onofrio R; Carter SL; Park K; Habegger L; Ambrogio L; Fennell T; Parkin M; Saksena G; Voet D; Ramos AH; Pugh TJ; Wilkinson J; Fisher S; Winckler W; Mahan S; Ardlie K; Baldwin J; Simons JW; Kitabayashi N; MacDonald TY; Kantoff PW; Chin L; Gabriel SB; Gerstein MB; Golub TR; Meyerson M; Tewari A; Lander ES; Getz G; Rubin MA; Garraway LA
Nature; 2011 Feb; 470(7333):214-20. PubMed ID: 21307934
[TBL] [Abstract][Full Text] [Related]
16. EZH2-induced lysine K362 methylation enhances TMPRSS2-ERG oncogenic activity in prostate cancer.
Zoma M; Curti L; Shinde D; Albino D; Mitra A; Sgrignani J; Mapelli SN; Sandrini G; Civenni G; Merulla J; Chiorino G; Kunderfranco P; Cacciatore A; Kokanovic A; Rinaldi A; Cavalli A; Catapano CV; Carbone GM
Nat Commun; 2021 Jul; 12(1):4147. PubMed ID: 34230470
[TBL] [Abstract][Full Text] [Related]
17. Genomic study of replication initiation in human chromosomes reveals the influence of transcription regulation and chromatin structure on origin selection.
Karnani N; Taylor CM; Malhotra A; Dutta A
Mol Biol Cell; 2010 Feb; 21(3):393-404. PubMed ID: 19955211
[TBL] [Abstract][Full Text] [Related]
18. ETS family transcription factors collaborate with alternative signaling pathways to induce carcinoma from adult murine prostate cells.
Zong Y; Xin L; Goldstein AS; Lawson DA; Teitell MA; Witte ON
Proc Natl Acad Sci U S A; 2009 Jul; 106(30):12465-70. PubMed ID: 19592505
[TBL] [Abstract][Full Text] [Related]
19. Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models.
Linn DE; Bronson RT; Li Z
PLoS One; 2015; 10(3):e0120628. PubMed ID: 25780911
[TBL] [Abstract][Full Text] [Related]
20. Abnormal expression of the ERG transcription factor in prostate cancer cells activates osteopontin.
Flajollet S; Tian TV; Flourens A; Tomavo N; Villers A; Bonnelye E; Aubert S; Leroy X; Duterque-Coquillaud M
Mol Cancer Res; 2011 Jul; 9(7):914-24. PubMed ID: 21669963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
